Claus Andersen is a Solicitor in the Corporate department at Freeths LLP. He advises companies, entrepreneurs, and investors in the Technology and Life Sciences sector on mergers and acquisitions, shareholders’ agreements, joint ventures, fundraising, corporate structures, regulatory matters, corporate governance (including the Bribery Act 2010), licensing, and collaboration agreements. His clients range from start-ups to publicly listed companies and include leading pharmaceutical, MedTech, HealthTech, and Biotech businesses, as well as their suppliers and subcontractors.

Claus is recognised for providing quick, pragmatic, and efficient advice that enables clients to achieve their commercial objectives. He understands that every client has unique requirements and ensures his guidance is tailored to support their specific goals.

Freeths LLP is a full-service, nationwide law firm with offices in 13 UK cities. Ranked among the UK’s top 50, the firm specialises in providing business law advice across corporate, commercial, intellectual property, finance, real estate, employment, dispute resolution, and regulatory matters. Freeths works with clients ranging from start-ups and SMEs to companies listed on the main markets in Europe, Asia, and North America, with particular strength in the Technology and Life Sciences sectors.

Eleanor is Director, UK Government and Political Affairs at AstraZeneca. Prior to joining AstraZeneca, Eleanor has spent over a decade working across UK and global life science policy and government affairs roles at GSK, Haleon and Incisive Health, at increasing levels of seniority. Eleanor holds an MSc in Global Health Policy and Economics from LSE.

Tom Davis joined Europe’s largest digital-first healthcare provider, Kry Livi, as UK Medical Director in spring 2024 where he works with NHS services, private health insurers and employers in the UK to support them in meeting patient demand and enhancing care journeys. A qualified GP with leadership, governance, and management skills, he brings extensive experience of board level. Since Summer 2024 Tom has taken responsibility for the entire UK operations as Country Manager.

He joined Kry Livi from the NHS in England and Wales where he held Senior Medical and Executive roles across a number of sectors within healthcare, including a period as the acting Chief Executive Officer (CEO) of the East of England Ambulance Service NHS Trust, where he was the Medical Director and Deputy CEO prior to this.

Tom studied at the Royal London Hospitals Medical School (Barts and the London) for his medicine doctorate and later went on to the University of Nottingham, where he graduated with a Masters in Sports and Exercise Medicine. He is an advocate for workplace wellbeing, leading coaching and mentoring sessions to empower healthcare professionals and colleagues to get the best out of their careers by balancing self care, productivity and personal fulfilment.

Daisy is UK Country Manager for Mindler, a digital mental health provider offering therapeutic support to those who need it most, in collaboration with public health systems and insurers.

With a background in health and social care consulting and health tech start ups, Daisy joined Mindler via acquisition in February 2023 and has held the Country Manager role since June 2024. In this capacity, she is responsible for the operational and commercial delivery of Mindler’s UK business, with a focus on sustainable growth and expanding access to high-quality mental health support.

Dr Kristin-Anne Rutter development and now leads delivery of a collaborative life sciences strategy for the Cambridge cluster. The goal of that strategy is to accelerate the creation of breakthrough scientific discoveries, demonstrate that they work in real world populations and then deliver them rapidly and at scale to benefit patients and grow the UK economy.

As part of that strategy, Kristin-Anne has established a number of programmes designed to attract funding into the life sciences sector, including an investor event during London Life Sciences Week, which showcases the most exciting new companies across both Cambridge and Oxford.

To boost industry-National Health Service (NHS) collaboration and innovation, Kristin-Anne is also delivering three major programmes: she leads the Secure Data Environment for the East of England, which helps researchers and AI developers access large patient datasets in a bid to find new treatments for common, yet currently incurable conditions. She helped develop the NHSE Innovation Ecosystem Programme, which lays out in depth how the NHS can become a better innovation partner to industry. And she is establishing Innovation Landing Zones in Cambridge NHS trusts, to support the testing and adoption of innovation.

Kristin-Anne joined CUHP from McKinsey & Company, where she was a partner focussing on improvement and innovation in healthcare delivery and the founder of the McKinsey Health Tech Network.

Prior to joining McKinsey, Kristin-Anne worked as a medical doctor in Iceland, and she currently chairs the audit and risk committee of MSI International.

Jake is Head of Life Sciences and Public Sector Partnerships for the Data for Research and Development programme at NHS England. Here he leads global stakeholder engagement and commercial development for the £200m+ NHS Secure Data Environment Network as national infrastructure enabling secure access to health data for research across England. He is also recognised as one of the top 100 senior digital change leaders across England’s health and care system.

As an award-winning digital health and health data specialist, Jake has a particular passion for Anglo-Swedish collaboration in the life sciences sector. This year, he completed capstone research comparing the secondary use of health data for commercial research across England and Sweden. He also is actively involved in the Swedish health data ecosystem, having served as a ‘Next Generation Leader’ at the Swedish Chamber of Commerce to the UK, participating in the recent UK-Sweden health data delegation under the bilateral MoU and acting as an independent international advisor to OMOP4Sweden (omop.se).

Marika Amartey is the Head of the Science and Innovation Office for the Swedish Ministry of Climate and Enterprise at the Embassy of Sweden in London, building and managing strategic collaboration between Sweden and the UK in the areas of research, innovation and higher education. Marika was seconded national expert to the European Commission in Brussels at the Directorate General for Communications Networks, Content and Technology, managing multi-national research and innovation collaboration projects, as well as projects for individual researchers and SMEs. Previously Marika worked as a management and technical consultant in the private sector in the Baltic and Benelux regions, covering areas of strategic business development, market expansion and global sales growth. Marika has a seat at the bilateral working group for the MoU for the Life Sciences between Sweden and UK, is an active evaluator and reviewer for the European Commission Expert Management Team, and is an executive board member for the Society of Swedish Engineers in the UK. She holds an M.Sc. in Economics and Public Administration and speaks Swedish, English and French.